Back to top
more

Aflac (AFL)

(Delayed Data from NYSE)

$98.09 USD

98.09
2,768,318

-1.27 (-1.28%)

Updated Aug 1, 2025 03:59 PM ET

After-Market: $98.10 +0.01 (0.01%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.75%
2Buy17.82%
3Hold9.58%
4Sell5.28%
5Strong Sell2.61%
S&P50011.30%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

2-Buy of 5   2      

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value D Growth C Momentum D VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 31% (170 out of 246)

Industry: Insurance - Accident and Health

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Aflac Incorporated was formed in 1973 under the laws of the state of Georgia. The company is a general business holding company and oversees the operations of its subsidiaries by providing management services and making capital available. Its principal business is voluntary supplemental and life insurance, which is marketed and administered through American Family Life Assurance Company of Columbus (Aflac) in the United States (Aflac U.S.) and, effective Apr 1, 2018, through Aflac Life Insurance Japan Ltd. in Japan (Aflac Japan).

Zacks Equity Research

Here's Why You Should Add Aflac (AFL) Stock to Portfolio Now

by Zacks Equity Research

Aflac Inc. (AFL) boasts an excellent franchise and strong market position in supplemental health insurance in both Japan and the U.S.

    Sheraz Mian headshot

    New Research Reports for Oracle, Chubb, AstraZeneca & Others

    by Sheraz Mian

    Today's Research Daily features new research reports on 16 major stocks, including Oracle (ORCL), Chubb (CB) and AstraZeneca (AZN).

      Zacks Equity Research

      MetLife (MET) Q1 Earnings & Revenues Top Estimates, Grow Y/Y

      by Zacks Equity Research

      MetLife, Inc.'s (MET) earnings of $1.46 per share beat the Zacks Consensus Estimate by 14.96% and were up 12.3% year over year.

        Zacks Equity Research

        Lincoln National (LNC) Earnings Beat in Q1, Revenues Miss

        by Zacks Equity Research

        Lincoln National Corporation's (LNC) earnings of $1.92 per share surpassed the Zacks Consensus Estimate by 18.5%.

          Zacks Equity Research

          AIG (AIG) Beats on Q1 Earnings, Growth Initiatives On Track

          by Zacks Equity Research

          American International Group Inc. (AIG) eanings of $1.36 per share surpassed the Zacks Consensus Estimate by a good 22.5%.

            Zacks Equity Research

            Aflac (AFL) Q1 Earnings Beat, Revenues Miss, Guidance Intact

            by Zacks Equity Research

            Aflac Inc.'s (AFL) first-quarter 2017 earnings of $1.67 per share surpassed the Zacks Consensus Estimate by 3.09% but decreased 3.5% year over year.

              Zacks Equity Research

              Insurance Stocks Earnings Slated on Apr 27: AFL, AJG & More

              by Zacks Equity Research

              For the insurance sector overall, the results for the first quarter reflect effects of an increase in disposable income on the back of continued growth in the economy.

                Zacks Equity Research

                Is Aflac a Suitable Stock for Value Investors?

                by Zacks Equity Research

                Let's focus on Aflac Incorporated (AFL) stock and find out if it is a good choice for value-oriented investors right now or not.

                  Zacks Equity Research

                  Will Aflac (AFL) Q1 Earnings Gain on Product Mix Change?

                  by Zacks Equity Research

                  Our proven model does not conclusively show that Aflac is likely to beat on earnings this quarter.

                    Zacks Equity Research

                    Is it Time to Offload Aflac (AFL) Stock from Your Portfolio?

                    by Zacks Equity Research

                    In the past one year, the shares of Aflac Inc. (AFL) have underperformed the Zacks categorized Insurance-Accident and Health Insurance industry.

                      Zacks Equity Research

                      Why Is Aflac Incorporated (AFL) Up 8.7% Since the Last Earnings Report?

                      by Zacks Equity Research

                      Aflac Incorporated (AFL) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

                        Sweta Killa headshot

                        Insurance ETFs Leading Financial Sector in Q4 Earnings

                        by Sweta Killa

                        Earnings from the insurance industry have particularly been strong with most players beating both our earnings and revenue estimates.

                          Zacks Equity Research

                          Aflac (AFL): Moving Average Crossover Alert

                          by Zacks Equity Research

                          Aflac Incorporated (AFL) could be a stock to avoid from a technical perspective, as the firm is seeing unfavorable trends on the moving average crossover front.

                            Zacks Equity Research

                            Aflac (AFL) Earnings Miss, Revenues Beat Estimates in Q4

                            by Zacks Equity Research

                            Aflac Incorporated's (AFL) fourth-quarter 2016 operating earnings per share of $1.54 missed the Zacks Consensus Estimate of $1.64 by about 6.1% and also decreased 1.3% year over year.

                              Zacks Equity Research

                              Insurance Stock Q4 Earnings on Jan 31: CB, WRB, AFL, RNR

                              by Zacks Equity Research

                              Let's find out how these four insurers - CB, WRB, AFL, RNR might perform when they report their quarterly numbers on Jan 31.

                                Zacks Equity Research

                                Will Aflac (AFL) Disappoint Investors this Earnings Season?

                                by Zacks Equity Research

                                Aflac Inc. (AFL) is scheduled to report fourth-quarter and full-year 2016 results on Jan 31 after the closing bell.

                                  Zacks Equity Research

                                  Aflac's Senior Unsecured Notes Get Debt Rating from Moody's

                                  by Zacks Equity Research

                                  Aflac Incorporated (AFL) recently received rating action from Moody's Investors Service, a wing of Moody's Corporation (MCO).

                                    Zacks Equity Research

                                    New Strong Sell Stocks for January 6th

                                    by Zacks Equity Research

                                    Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List for Friday

                                      Zacks Equity Research

                                      New Strong Sell Stocks for January 4th

                                      by Zacks Equity Research

                                      Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List for Wednesday

                                        Zacks Equity Research

                                        Aflac and its Units Get Rating Affirmation from A.M Best

                                        by Zacks Equity Research

                                        Aflac Incorporated (AFL) and its affiliates recently received rating action from credit rating giant, A.M. Best.

                                          Zacks Equity Research

                                          The Zacks Analyst Blog Highlights: Chevron, Glaxo, Aflac, Novo Nordisk and MGM Resorts

                                          by Zacks Equity Research

                                          The Zacks Analyst Blog Highlights: Chevron, Glaxo, Aflac, Novo Nordisk and MGM Resorts

                                            Mark Vickery headshot

                                            Top Research Reports for 9th November, 2016

                                            by Mark Vickery

                                            Today's Research Daily features new research reports on 16 major stocks, including Chevron (CVX), Glaxo (GSK) and Aflac (AFL).